Logo image of BRZE

BRAZE INC-A (BRZE) Stock Fundamental Analysis

USA - NASDAQ:BRZE - US10576N1028 - Common Stock

28.74 USD
+0.53 (+1.88%)
Last: 11/14/2025, 8:00:01 PM
28.99 USD
+0.25 (+0.87%)
After Hours: 11/14/2025, 8:00:01 PM
Fundamental Rating

4

Overall BRZE gets a fundamental rating of 4 out of 10. We evaluated BRZE against 281 industry peers in the Software industry. While BRZE seems to be doing ok healthwise, there are quite some concerns on its profitability. BRZE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BRZE had positive earnings in the past year.
BRZE had a positive operating cash flow in the past year.
BRZE had negative earnings in each of the past 5 years.
In multiple years BRZE reported negative operating cash flow during the last 5 years.
BRZE Yearly Net Income VS EBIT VS OCF VS FCFBRZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

With a Return On Assets value of -10.64%, BRZE is not doing good in the industry: 63.35% of the companies in the same industry are doing better.
BRZE's Return On Equity of -18.17% is in line compared to the rest of the industry. BRZE outperforms 42.35% of its industry peers.
Industry RankSector Rank
ROA -10.64%
ROE -18.17%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
BRZE Yearly ROA, ROE, ROICBRZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

With a Gross Margin value of 68.79%, BRZE perfoms like the industry average, outperforming 50.89% of the companies in the same industry.
In the last couple of years the Gross Margin of BRZE has grown nicely.
BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
BRZE Yearly Profit, Operating, Gross MarginsBRZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

6

2. Health

2.1 Basic Checks

BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRZE has more shares outstanding than it did 1 year ago.
BRZE has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BRZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BRZE Yearly Shares OutstandingBRZE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BRZE Yearly Total Debt VS Total AssetsBRZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.96 indicates that BRZE is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.96, BRZE is doing good in the industry, outperforming 67.62% of the companies in the same industry.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.96
ROIC/WACCN/A
WACC10.94%
BRZE Yearly LT Debt VS Equity VS FCFBRZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

BRZE has a Current Ratio of 1.37. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
BRZE has a Current ratio of 1.37. This is comparable to the rest of the industry: BRZE outperforms 43.06% of its industry peers.
BRZE has a Quick Ratio of 1.37. This is a normal value and indicates that BRZE is financially healthy and should not expect problems in meeting its short term obligations.
BRZE has a Quick ratio (1.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
BRZE Yearly Current Assets VS Current LiabilitesBRZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 820.00% over the past year.
The Revenue has grown by 22.16% in the past year. This is a very strong growth!
Measured over the past years, BRZE shows a very strong growth in Revenue. The Revenue has been growing by 43.83% on average per year.
EPS 1Y (TTM)820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)22.16%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%23.79%

3.2 Future

The Earnings Per Share is expected to grow by 56.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 17.76% on average over the next years. This is quite good.
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y72.42%
EPS Next 5Y56.56%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.73%
Revenue Next 5Y17.76%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BRZE Yearly Revenue VS EstimatesBRZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BRZE Yearly EPS VS EstimatesBRZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

BRZE is valuated quite expensively with a Price/Earnings ratio of 79.83.
The rest of the industry has a similar Price/Earnings ratio as BRZE.
BRZE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.89.
A Price/Forward Earnings ratio of 54.89 indicates a quite expensive valuation of BRZE.
BRZE's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of BRZE to the average of the S&P500 Index (34.59), we can say BRZE is valued expensively.
Industry RankSector Rank
PE 79.83
Fwd PE 54.89
BRZE Price Earnings VS Forward Price EarningsBRZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRZE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 116.87
EV/EBITDA N/A
BRZE Per share dataBRZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BRZE's earnings are expected to grow with 72.42% in the coming years.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y70.55%
EPS Next 3Y72.42%

0

5. Dividend

5.1 Amount

No dividends for BRZE!.
Industry RankSector Rank
Dividend Yield N/A

BRAZE INC-A

NASDAQ:BRZE (11/14/2025, 8:00:01 PM)

After market: 28.99 +0.25 (+0.87%)

28.74

+0.53 (+1.88%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-04 2025-09-04/amc
Earnings (Next)12-15 2025-12-15/amc
Inst Owners72.77%
Inst Owner Change-0.56%
Ins Owners5.64%
Ins Owner Change5.58%
Market Cap3.20B
Revenue(TTM)654.62M
Net Income(TTM)-108.79M
Analysts84.62
Price Target45.73 (59.12%)
Short Float %6.55%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)220.59%
Min EPS beat(2)50.17%
Max EPS beat(2)391.01%
EPS beat(4)4
Avg EPS beat(4)272.62%
Min EPS beat(4)50.17%
Max EPS beat(4)523.5%
EPS beat(8)8
Avg EPS beat(8)199.67%
EPS beat(12)12
Avg EPS beat(12)146.67%
EPS beat(16)16
Avg EPS beat(16)117.22%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)0.14%
Max Revenue beat(2)3.8%
Revenue beat(4)4
Avg Revenue beat(4)1.38%
Min Revenue beat(4)0.14%
Max Revenue beat(4)3.8%
Revenue beat(8)8
Avg Revenue beat(8)1.72%
Revenue beat(12)12
Avg Revenue beat(12)1.7%
Revenue beat(16)16
Avg Revenue beat(16)2.89%
PT rev (1m)-0.63%
PT rev (3m)-0.37%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)194.56%
EPS NY rev (1m)-0.16%
EPS NY rev (3m)137.69%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)2.23%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 79.83
Fwd PE 54.89
P/S 4.89
P/FCF 116.87
P/OCF 86.97
P/B 5.34
P/tB 12.14
EV/EBITDA N/A
EPS(TTM)0.36
EY1.25%
EPS(NY)0.52
Fwd EY1.82%
FCF(TTM)0.25
FCFY0.86%
OCF(TTM)0.33
OCFY1.15%
SpS5.88
BVpS5.38
TBVpS2.37
PEG (NY)0.6
PEG (5Y)N/A
Graham Number6.6
Profitability
Industry RankSector Rank
ROA -10.64%
ROE -18.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.79%
FCFM 4.18%
ROA(3y)-15.85%
ROA(5y)-15.52%
ROE(3y)-27.38%
ROE(5y)-29.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.04%
GM growth 5Y1.88%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 73.75%
Cap/Sales 1.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 3.96
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)240.58%
Cap/Depr(5y)230.69%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)820%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y133.15%
EPS Next 2Y70.55%
EPS Next 3Y72.42%
EPS Next 5Y56.56%
Revenue 1Y (TTM)22.16%
Revenue growth 3Y35.6%
Revenue growth 5Y43.83%
Sales Q2Q%23.79%
Revenue Next Year21.91%
Revenue Next 2Y19.59%
Revenue Next 3Y18.73%
Revenue Next 5Y17.76%
EBIT growth 1Y10.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year761.05%
EBIT Next 3Y188.12%
EBIT Next 5Y120.97%
FCF growth 1Y201.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y294.75%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZE INC-A / BRZE FAQ

Can you provide the ChartMill fundamental rating for BRAZE INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to BRZE.


What is the valuation status of BRAZE INC-A (BRZE) stock?

ChartMill assigns a valuation rating of 3 / 10 to BRAZE INC-A (BRZE). This can be considered as Overvalued.


How profitable is BRAZE INC-A (BRZE) stock?

BRAZE INC-A (BRZE) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for BRZE stock?

The Price/Earnings (PE) ratio for BRAZE INC-A (BRZE) is 79.83 and the Price/Book (PB) ratio is 5.34.


What is the earnings growth outlook for BRAZE INC-A?

The Earnings per Share (EPS) of BRAZE INC-A (BRZE) is expected to grow by 133.15% in the next year.